Back

Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome

18 June 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Young Investigator Award: Basic and Translational Science Clinical mechanisms (Cardiac arrhythmias, non invasive) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Doctor Deniz Akdis

University Heart Center, Zurich (Switzerland)

5 More presentations in this session

Presentation thumbnail
High risk of heart failure in desmoglein-2 mutation carriers in arrhythmogenic right ventricular dysplasia/cardiomyopathy
Doctor A. Hermida (Paris, FR)
Abstract Slides Video
Presentation thumbnail
The antiarrhythmic effects of melatonin in different pathological conditions
Doctor T. Egan Benova (Bratislava, SK)
Abstract
Presentation thumbnail
Integration of noninvasive imaging of repolarization and cellular modelling for personalized medicine in primary ventricular fibrillation
Doctor M. Cluitmans (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Optogenetic ablation of spiral wave arrhythmias by creating light lesions
Ms I. Feola (Leiden, NL)
Abstract
Presentation thumbnail
Percutaneous partially-insulated epicardial tool allows low defibrillation tresholds and prevents extra-cardiac stimulation
Doctor M. Pesl (Brno, CZ)
Abstract

Access the full session

Session thumbnail
Young Investigator Award: Basic and Translational Science

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources